UE5CA246744
Cooperative Agreement
Overview
Grant Description
The cell and gene therapy toolkit for junior faculty.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Philadelphia,
Pennsylvania
191045128
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/31/23 to 03/31/24 and the total obligations have increased 95% from $319,685 to $624,922.
Trustees Of The University Of Pennsylvania was awarded
The cell and gene therapy toolkit for junior faculty
Cooperative Agreement UE5CA246744
worth $624,922
from National Cancer Institute in April 2020 with work to be completed primarily in Philadelphia Pennsylvania United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.393 Cancer Cause and Prevention Research.
The Cooperative Agreement was awarded through grant opportunity NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 7/19/24
Period of Performance
4/1/20
Start Date
3/31/24
End Date
Funding Split
$624.9K
Federal Obligation
$0.0
Non-Federal Obligation
$624.9K
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for UE5CA246744
Transaction History
Modifications to UE5CA246744
Additional Detail
Award ID FAIN
UE5CA246744
SAI Number
UE5CA246744-3432871370
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
GM1XX56LEP58
Awardee CAGE
7G665
Performance District
PA-03
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $658,430 | 100% |
Modified: 7/19/24